UMC Utrecht

US brain-computer-interface startup Paradromics is establishing itself as a major player in the neural-device space, with the Food and Drug Administration green-lighting a human trial to test its ability in restoring speech to people with paralysis.

Good news for the 51 million Americans with chronic pain: Scientists have unraveled the neuronal disturbances that can see acute pain turn into a long-term nightmare, and with some targeted cell therapy, could potentially stop this process altogether.

Researchers have combined two different 3D-printing techniques to produce artificial blood-vessel prototypes. The process created tubes that can be covered in live cells while retaining the strength they need to function under pressure.